Over a more than 30-year career in mass tort and complex litigation defense, Alston & Bird LLP's Jane Thorpe has built a reputation as a savvy strategist and tenacious team player who doesn't shy away from the nitty-gritty science at the heart of the case, making her one of Law360's 10 Most Admired Product Liability Attorneys.
An uncanny ability to think like, connect with and entertain a jury in high-stakes trial settings has made Dechert LLP's Diane Sullivan one of Law360's Most Admired Product Liability Attorneys.
Sills Cummis & Gross PC's Beth Rose has spent her career crafting winning strategies for pharmaceutical and medical device companies facing product liability and mass tort litigation while earning a reputation as a quick thinker and a team player, making her one of Law360's 10 Most Admired Product Liability Attorneys.
Handling sympathetic witnesses in product liability cases is notoriously difficult. Faegre & Benson LLP's Joe Price is among the best at tactfully questioning such witnesses while still making the best case for his client, one of the many skills that make him one of Law360's 10 Most Admired Product Liability Attorneys.
Combining professionalism and poise with never-ending enthusiasm and eternal optimism, Shook Hardy & Bacon LLP's Harvey L. Kaplan has played a vital role in securing a slew of major defense verdicts for some of the leading players in the pharmaceutical and medical device industry during the past 40 years, a feat that has earned him a place among Law360's 10 Most Admired Product Liability Attorneys.
Pepper Hamilton LLP's Nina Gussack has proved tough enough to tackle state attorneys general on behalf of pharmaceutical giants while making sure that even new associates in the firm's health effects group play an active role in the litigation team, earning her a spot as one of Law360's 10 Most Admired Product Liability Attorneys.
Skadden Arps Slate Meagher & Flom LLP's Sheila Birnbaum has spent her career blazing trails both for companies facing major mass tort actions and for women in the legal profession, earning a spot on Law360's list of the 10 Most Admired Product Liability Attorneys.
Reed Smith LLP's Michael Brown is the rare one-stop-shop defense lawyer who writes killer briefs and excels at arguing appeals and swaying juries, earning him the respect of his peers and a place among Law360's 10 Most Admired Product Liability Attorneys.
Seattle-based plaintiffs firm Hagens Berman Sobol Shapiro LLP, which has taken a lead role in the Toyota Motor Corp. multidistrict litigation, has opened a Washington office to better serve area clients that include federal agencies.
Jones Day has snagged a product liability partner from Latham & Watkins LLP and a mergers and acquisitions attorney from Bingham McCutchen LLP for two of its offices in California.
The former deputy chief counsel of the U.S. Food and Drug Administration has joined Sidley Austin LLP, adding experience to the firm's food, drug and medical device regulatory practice.
Seasoned litigator Kurt Stitcher has joined Baker & Daniels LLP from Levenfeld Pearlstein LLC, bringing 20 years of experience in product liability, antitrust and white collar defense.
Three former Wilson Elser Moskowitz Edelman & Dicker LLP attorneys have joined Hinshaw & Culbertson LLP, boosting the firm's products liability practice.
McDermott Will & Emery LLP has lured former U.S. Food and Drug Administration official James S. Cohen from Buchanan Ingersoll & Rooney PC to take charge of the firm's FDA practice in its Washington office.
A team of attorneys led by health care product liability lawyer Ewa Rutkowska has jumped from Hogan Lovells to the Warsaw, Poland, offices of Baker & McKenzie LLP, where it will advise pharmaceutical sector clients, the law firm said Tuesday.
Thompson Hine LLP is expanding its product liability team with the addition of former Arnold & Porter LLP partner Fern Phillips O’Brian, who comes to the firm with a practice that spans the health care and technology industries.
U.S. Attorney for the Southern District of California Karen P. Hewitt will join Jones Day's San Diego office as a partner in its trial practice after 18 years in public service.
Barnes & Thornburg LLP has nabbed Thomas A. Boardman, former deputy general counsel at 3M Co., who spent 36 years coordinating mass tort defenses and other legal matters for the St. Paul, Minn.-based conglomerate.
The U.S. Food and Drug Administration has tapped Centers for Disease Control and Prevention dynamo Dr. David L. Ashley to join the agency's tobacco products regulation unit as its first director for the Office of Science.
Former EpsteinBeckerGreen partner Elizabeth Davis, who specializes in environmental as well as consumer product safety issues, has joined Thompson Hine LLP’s Atlanta office.
Following demands for tougher oversight of energy drinks, the U.S. Food and Drug Administration responded recently that it had no immediate plans to change any relevant laws. If the FDA follows the Canadian authorities' lead on regulating energy drinks, it likely will not introduce any age-related bans but may only change some labeling laws, say Daragh Hoey of Fulbright & Jaworski LLP and Martha Healey of Norton Rose LLP.
In the recent ruling of Astiana v. Hain Celestial Group Inc., the U.S. District Court for the Northern District of California dismissed a putative class action alleging that cosmetics manufacturers' "natural" labels were misleading. The opinion reinvigorates a judicial approach that could even the balance between plaintiffs and defendants in such class action, says William Dance of Tucker Ellis LLP.
By reviewing Greb v. Diamond International Corporation and Robinson v. SSW Inc., the California Supreme Court will resolve whether an out-of-state state-dissolved corporation can be subject to suit in California courts after its state's continuance period expires. There are two plausible paths the court could take to reach a result in which non-California corporations and their shareholders and insurers could rest in peace in the corporate afterlife, say attorneys with Miles & Stockbridge PC.
While most compliance and supply chain professionals by now generally appreciate the California Transparency in Supply Chains Act’s objective and basic mechanics, a visit to the homepage of your favorite manufacturer or retailer is likely to reveal that there continues to be a surprising level of confusion over something exceptionally basic: namely, where the disclosure must be announced, say attorneys with Perkins Coie LLP.
This year is sure to bring a number of significant changes to the food and beverage industry, especially given the 2012 election results and the continued momentum of several hot topics from 2012 that attracted the attention of government officials, agencies and the general public. Food labeling, food safety and taxes on sweetened beverages are a few areas in which we expect to see such changes, say attorneys with McGuireWoods LLP and McGuireWoods Consulting LLC.
The New Year is still in its infancy, and there is no better time to craft a list of professional resolutions. To ease into the process, consider seven easy steps for super-charging your marketing and communications efforts in 2013, says Michael Bond of Blattel Communications.
In recent years, there has been a growing number of consumer fraud class actions brought against the manufacturers of regulated products. The recent case Taradejna v. General Mills Inc. reminds defense attorneys everywhere that when defending claims involving regulated products, it is well worth considering whether the doctrine of primary jurisdiction should result in the dismissal of the plaintiff’s claim, says Brendan Krasinski of Alston & Bird LLP.
How do we prepare a witness, a layperson having no training in the art of litigation, to give an effective and memorable performance? A number of tips, when incorporated into your practice of law, will surely strengthen your witness's presentation at deposition and trial and the overall merits of your case, says Erika Ronquillo of Marshall Dennehey Warner Coleman & Goggin PC.
Recently, in Wyeth Inc. v. Weeks, the Supreme Court of Alabama adopted brand-name manufacturer liability for a generic drug sold by another company, becoming the first state supreme court to do so. The holding in this case remains the minority view, significantly outnumbered by the "traditional" products liability theory, and could greatly impact brand-name manufacturers who historically have enjoyed an exit strategy based on product identification, say attorneys with Morrison & Foerster LLP.
New Year’s resolutions may already be waning, but consumers continue to purchase foods and beverages bearing the "all natural" labels in an effort to eat healthier. As seen by several recent cases, the only food trend hotter than buying "natural" foods and beverages is suing the manufacturers that produce them, says Scott Galla with Cozen O'Connor.